OncoQuest Announces Presentation of Pre-Clinical Data from its IgE Based Immunotherapy Platform Technology at the …PR Newswire (press release)The presentation demonstrates the generation of an antigen specific immunity that protected against pancreat… Continue reading
Labiotech.eu (blog)This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body UnprotectedLabiotech.eu (blog)CAR-T cell therapies have been hailed as a “miracle cure” for cancer. However, the fist ones, which were approved just this year,… Continue reading
FierceBiotech |
Locus raises $19M to take CRISPR-based antimicrobial ‘Pac-Man’ into clinic
FierceBiotech There are plenty of companies looking at using the gene-editing technology CRISPR-Cas9 to treat human diseases, but Locus is the only company in the world using a different pathway—CRISPR-Cas3—to tackle the pressing problem of multidrug-resistant … Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 AntimicrobialsPR Newswire (press release) |
FierceBiotech |
Locus raises $19M to take CRISPR-based antimicrobial ‘Pac-Man’ into clinic
FierceBiotech There are plenty of companies looking at using the gene-editing technology CRISPR-Cas9 to treat human diseases, but Locus is the only company in the world using a different pathway—CRISPR-Cas3—to tackle the pressing problem of multidrug-resistant … Locus Biosciences Closes $19 Million Series A Led by ARTIS Ventures for CRISPR-Cas3 AntimicrobialsMarkets Insider How Locus landed $19M from ARTIS, TencentTriangle Business Journal |
Herald and News |
Local dogs, animal hospital part of stem cell research program
Herald and News “If this stem cell thing works, it’ll give him a whole new lease on life.” Tank is one of 27 dogs involved with the program at West Ridge Animal Hospital in Klamath Falls. Animal Cell Therapies, a San Diego company with more than nine years experience … |
|
How robots could solve the antibiotics production crisis
Phys.Org But thanks to the huge technological advances in recent years, our team at the University of Manchester’s Synthetic Biology Research Centre, SYNBIOCHEM, has been able to marry the strengths of biology with the power of engineering to find new ways to … |